Cargando…

Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis

Background: High-grade neuroendocrine carcinoma (NEC) is a rare and aggressive variant of bladder cancer. Considering its rarity, its therapeutic management is challenging and not standardized. Methods: We analyzed data extracted from the Surveillance, Epidemiology, and End Results (SEER) registry t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mollica, Veronica, Massari, Francesco, Andrini, Elisa, Rosellini, Matteo, Marchetti, Andrea, Nuvola, Giacomo, Tassinari, Elisa, Lamberti, Giuseppe, Campana, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406377/ https://www.ncbi.nlm.nih.gov/pubmed/36005199 http://dx.doi.org/10.3390/curroncol29080461

Ejemplares similares

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
por: Tassinari, Elisa, et al.
Publicado: (2022)

Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw
por: Mollica, Veronica, et al.
Publicado: (2022)

The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?
por: Marchetti, Andrea, et al.
Publicado: (2021)

PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?
por: Marchetti, Andrea, et al.
Publicado: (2022)

An Update on Appendiceal Neuroendocrine Tumors
por: Andrini, Elisa, et al.
Publicado: (2023)

An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
por: Mollica, Veronica, et al.
Publicado: (2021)

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
por: Brighi, Nicole, et al.
Publicado: (2023)

Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
por: Andrini, Elisa, et al.
Publicado: (2022)

Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institution
por: Di Federico, Alessandro, et al.
Publicado: (2021)

Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review
por: Zappi, Arianna, et al.
Publicado: (2023)

Prognosis of patients with neuroendocrine tumor: a SEER database analysis
por: Man, Da, et al.
Publicado: (2018)

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
por: Abdelmalak, Rebecca, et al.
Publicado: (2021)

Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation
por: Chen, Xiaoyue, et al.
Publicado: (2023)

Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?
por: Ricco, Gianluca, et al.
Publicado: (2021)

Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort
por: Li, Yihe, et al.
Publicado: (2023)

The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database
por: Zheng, Bo-Hao, et al.
Publicado: (2022)

Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis
por: Chen, Jinghua, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for neuroendocrine prostate cancer, based on the SEER database
por: Chen, Siming, et al.
Publicado: (2023)

Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases
por: Song, Huixin, et al.
Publicado: (2023)

Glioblastoma in the setting of prior lower grade gliomas – insights from SEER database
por: Nguyen, Ha Son, et al.
Publicado: (2018)

Regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis
por: Mehrvarz Sarshekeh, Amir, et al.
Publicado: (2017)

Prognostic Evaluation of Patients with Rectal Neuroendocrine Neoplasms and Hepatic Metastases: A SEER Database Analysis
por: Yan, Lijun, et al.
Publicado: (2022)

Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review
por: Cai, Xing-Chen, et al.
Publicado: (2022)

Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population‐based analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2022)

Small cell neuroendocrine carcinoma with adenocarcinoma and high grade squamous intraepithelial neoplasia of the cervix
por: Gurubalan, Guralarasan, et al.
Publicado: (2023)

Do neuroendocrine carcinomas and mixed neuroendocrine–non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A SEER database analysis of 12,878 cases
por: Shi, Huiying, et al.
Publicado: (2020)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis
por: Li, Jinluan, et al.
Publicado: (2020)

Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis
por: Xiong, Lan, et al.
Publicado: (2022)

The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database
por: Wu, Zhengqi, et al.
Publicado: (2022)

Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016
por: Liu, Miao, et al.
Publicado: (2023)

Ethnicity and survival in bladder cancer: a population-based study based on the SEER database
por: Fang, Wei, et al.
Publicado: (2020)

Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study
por: Shen, C., et al.
Publicado: (2018)

Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database
por: Deng, Chong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e6tcim1137eg52suocibvt156m